These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 23037522)

  • 1. Safety and efficacy of a bolus injection of landiolol hydrochloride as a premedication for multidetector-row computed tomography coronary angiography.
    Osawa K; Miyoshi T; Sato S; Akagi N; Morimitsu Y; Nakamura K; Kohno K; Kusano K; Kanazawa S; Ito H
    Circ J; 2013; 77(1):146-52. PubMed ID: 23037522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multicenter, open-label study of an intravenous short-acting β1-adrenergic receptor antagonist landiolol hydrochloride for coronary computed tomography angiography by 16-slice multi-detector computed tomography in Japanese patients with suspected ischemic cardiac disease.
    Hirano M; Yamashina A; Hara K; Ikari Y; Jinzaki M; Iino M; Yamaguchi T; Tanimoto M; Kuribayashi S;
    Drugs R D; 2014 Sep; 14(3):185-94. PubMed ID: 25091378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, double-blind, placebo-controlled, phase III study of the short-acting β1-adrenergic receptor blocker landiolol hydrochloride for coronary computed tomography angiography in Japanese patients with suspected ischemic cardiac disease.
    Hirano M; Yamashina A; Hara K; Ikari Y; Jinzaki M; Iino M; Yamaguchi T; Tanimoto M; Kuribayashi S;
    Clin Drug Investig; 2014 Jan; 34(1):53-62. PubMed ID: 24174275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, double-blind, placebo-controlled, phase II dose-finding study of the short acting β1-blocker, landiolol hydrochloride, in patients with suspected ischemic cardiac disease.
    Jinzaki M; Hirano M; Hara K; Suzuki T; Yamashina A; Ikari Y; Iino M; Yamaguchi T; Kuribayashi S
    Int J Cardiovasc Imaging; 2013 Jun; 29 Suppl 1(Suppl 1):7-20. PubMed ID: 23784548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-finding study of landiolol hydrochloride: a short-acting β1-blocker for controlling heart rate during coronary computed-tomography angiography in Japan.
    Hirano M; Hara K; Ikari Y; Jinzaki M; Iino M; Hamada C; Kuribayashi S
    Adv Ther; 2013 Sep; 30(9):803-18. PubMed ID: 24062147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility of intravenous administration of landiolol hydrochloride for multislice computed tomography coronary angiography: initial experience.
    Isobe S; Sato K; Sugiura K; Mimura T; Kobayashi M; Meno C; Kato M; Ishii H; Murohara T
    Circ J; 2008 Nov; 72(11):1814-20. PubMed ID: 18827370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of landiolol hydrochloride, a new beta-blocker, in coronary computed tomography angiography.
    Isobe S; Sato K; Sugiura K; Mimura T; Kobayashi M; Meno C; Kato M; Ishii H; Murohara T
    Int J Cardiol; 2010 Mar; 139(2):196-8. PubMed ID: 18703245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of landiolol hydrochloride for atrial fibrillation after open heart surgery.
    Nishi H; Sakaguchi T; Miyagawa S; Yoshikawa Y; Fukushima S; Saito S; Ueno T; Kuratani T; Sawa Y
    Heart Vessels; 2013 Jul; 28(4):490-6. PubMed ID: 22661097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of Landiolol Hydrochloride as a Premedication for Producing an Appropriate Heart Rate for Multidetector-Row Computed Tomography Coronary Angiography.
    Koyoshi R; Shiga Y; Idemoto Y; Ueda Y; Tashiro K; Kuwano T; Kitajima K; Fujimi K; Kawamura A; Ogawa M; Miura SI
    J Clin Med Res; 2018 Jan; 10(1):22-26. PubMed ID: 29238430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of landiolol hydrochloride on cardiohemodynamics in patients who underwent coronary artery bypass grafting].
    Iwasawa K; Nakagawa H; Katou M; Yonezawa K; Nishizawa M; Yanagiya N
    Masui; 2005 Apr; 54(4):402-7. PubMed ID: 15852628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiation-Dose-Lowering Effects of Landiolol Hydrochloride in Coronary Angiography Using Computed Tomography (DELIGHT)　- A Prospective Multicenter Study.
    Kido T; Mochizuki T; Hirano M; Yamada Y; Tanaka R; Kanzaki S; Higashi M; Jinzaki M; Yoshioka K; Kuribayashi S
    Circ J; 2016 Apr; 80(5):1225-31. PubMed ID: 27019983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of an ultrashort-acting β1-blocker on left ventricular dysfunction.
    Ito N; Tashiro T; Morishige N; Nishimi M; Hayashida Y; Minematsu N; Kuwahara G; Sukehiro Y; Teratani H
    Heart Surg Forum; 2012 Aug; 15(4):E189-94. PubMed ID: 22917822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bolus administration of landiolol, a short-acting, selective beta1-blocker, to treat tachycardia during anesthesia: a dose-dependent study.
    Harasawa R; Hayashi Y; Iwasaki M; Kamibayashi T; Mashimo T
    J Cardiothorac Vasc Anesth; 2006 Dec; 20(6):793-5. PubMed ID: 17138082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Landiolol Hydrochloride on Hemodynamics in a Histamine-Induced Shock Model.
    Hirano M; Okamura T; Nagano T; Nonaka S; Shiroya T
    Drugs R D; 2021 Sep; 21(3):321-329. PubMed ID: 34128200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute hemodynamic effects of landiolol, an ultra-short-acting beta-blocker, in patients with acute coronary syndrome: preliminary study.
    Hoshi T; Sato A; Nishina H; Kakefuda Y; Wang Z; Noguchi Y; Aonuma K
    J Cardiol; 2012 Oct; 60(4):252-6. PubMed ID: 22835733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of landiolol hydrochloride on tachyarrhythmia after esophagectomy.
    Niwa Y; Koike M; Iwata N; Kobayashi D; Tanaka C; Fujii T; Nakayama G; Sugimoto H; Fujiwara M; Kodera Y
    Hepatogastroenterology; 2014 Sep; 61(134):1546-51. PubMed ID: 25436340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effectiveness and safety of landiolol hydrochloride, an ultra-short-acting β1-blocker, in postoperative patients with supraventricular tachyarrhythmias: a multicenter, randomized, double-blind, placebo-controlled study.
    Taenaka N; Kikawa S
    Am J Cardiovasc Drugs; 2013 Oct; 13(5):353-64. PubMed ID: 23818039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age and sex-related differences in dose-dependent hemodynamic response to landiolol hydrochloride during general anesthesia.
    Mizuno J; Yoshiya I; Yokoyama T; Yamada Y; Arita H; Hanaoka K
    Eur J Clin Pharmacol; 2007 Mar; 63(3):243-52. PubMed ID: 17211618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and pharmacodynamics of landiolol hydrochloride, an ultra short-acting beta1-selective blocker, in a dose escalation regimen in healthy male volunteers.
    Murakami M; Furuie H; Matsuguma K; Wanibuchi A; Kikawa S; Irie S
    Drug Metab Pharmacokinet; 2005 Oct; 20(5):337-44. PubMed ID: 16272751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of hepatic impairment on the pharmacokinetics and pharmacodynamics of landiolol hydrochloride, an ultra-short-acting beta1-blocker.
    Takahata T; Yasui-Furukori N; Sakamoto J; Suto K; Suto T; Tateishi T; Munakata A
    Drugs R D; 2005; 6(6):385-94. PubMed ID: 16274261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.